Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Herbal hope: new combo therapy targets Post-Surgery bathroom trips

NCT ID NCT07357324

Symptom relief Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding Lingze tablets, a traditional Chinese medicine, to the standard drug tamsulosin can help men who still wake up often at night to urinate after prostate surgery. About 136 men aged 50 and older will be randomly assigned to take either tamsulosin alone or tamsulosin plus Lingze for 8 weeks. Researchers will track nighttime bathroom visits, sleep quality, and side effects to see if the combination offers better relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lingze tablets (a traditional Chinese medicine) plus tamsulosin
What this could lead to
If it works, this could offer a better way to manage nighttime urination and poor sleep after prostate surgery, improving quality of life.
What could go wrong
This is a small, early-phase study with only 136 participants. The herbal supplement may not provide extra benefit over standard care, and side effects like dizziness or stomach upset are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 136 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients aged 50 years or older * History of transurethral holmium laser enucleation of the prostate (HoLEP) * Nocturia frequency ≥2 times per night * Documented bladder outlet obstruction * Presence of postoperative urinary incontinence and urgency symptoms * Ability to understand study procedures and provide written informed consent * Willingness to complete all scheduled follow-up visits and assessments Exclusion Criteria: * Known hypersensitivity or intolerance to tamsulosin hydrochloride, Lingze tablets, or any component of these medications * Active malignancy or severe cancer requiring treatment * Cognitive impairment, psychiatric disorder, or language barrier that prevents understanding of study requirements or completion of questionnaires * Severe multi-organ failure or dysfunction that would interfere with study participation * Previous enrollment in conflicting clinical trials within the past 30 days * Inability to comply with the medication regimen or study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostatic hyperplasia Nocturia associated with nocturnal polyuria

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine，Zhejiang University

    RECRUITING

    Yiwu, Zhejiang, 322000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.